Chen, Y., Dong, X., Wang, Q., Liu, Z., Dong, X., Shi, S., & Xiao, H. (2020). Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia. Front Pharmacol.
Citação norma ChicagoChen, Yan, Xiuhua Dong, QiuJu Wang, ZhiXi Liu, XinWei Dong, Sanjun Shi, and HongTao Xiao. "Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia." Front Pharmacol 2020.
Citação norma MLAChen, Yan, et al. "Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia." Front Pharmacol 2020.